文献速递疝与腹壁外科围术期管理与 ERAS

术前肉毒毒素A注射与组件分离技术在复杂腹壁重建中的倾向性匹配研究

Preoperative botulinum toxin A (BTA) injection versus component separation techniques (CST) in complex abdominal wall reconstruction (AWR): A propensity-scored matched study.
PubMed 文献 · Surgery · 2022-10-11

本研究为前瞻性单中心疝数据库的3:1倾向性匹配研究,比较2016至2021年开放腹壁重建中术前肉毒毒素A(BTA)与组件分离技术(CST)的结局。

要点

  • 术前BTA与CST在筋膜闭合率和疝复发率上无显著差异。
  • BTA组手术部位发生和手术部位感染发生率显著低于CST组。
  • 多因素分析中BTA与较低手术部位发生风险相关(OR=5.3,95%CI 1.4-34.4)。

核心结论

  • 术前BTA可达到与CST相似的筋膜闭合和复发结局,同时减少手术部位发生。

研究设计与样本

  • 前瞻性单中心疝特异性数据库的3:1倾向性匹配研究,匹配因素包括体重指数、缺损宽度、疝体积和CDC伤口分类。
  • 匹配后纳入CST组105例和BTA组35例,手术时间为2016至2021年。

主要发现

  • 多因素分析显示BTA与较低手术部位发生风险相关(OR=5.3,95%CI 1.4-34.4)。

关键数值与推荐

  • 两组吸烟、糖尿病和体重指数无差异(均P>0.5)。

临床怎么用

  • 对于复杂腹壁缺损,术前BTA可作为CST的替代辅助手段,以降低手术部位发生和感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complete fascial closure significantly reduces recurrence rates and wound complications in abdominal wall reconstruction. While component separation techniques have clear effectiveness in closing large abdominal wall defects, preoperative botulinum toxin A has emerged as an adjunct to aid in fascial closure. Few data exist comparing preoperative botulinum toxin A to component separation techniques, and the aim was to do so in a matched study. METHODS: A prospective, single-center, hernia-specific database was queried, and a 3:1 propensity-matched study of patients undergoing open abdominal wall reconstruction from 2016 to 2021 with botulinum toxin A versus component separation techniques was performed based on body mass index, defect width, hernia volume, and Centers for Disease Control and Prevention wound classification. Demographics, operative characteristics, and outcomes were evaluated. RESULTS: Matched patients included 105 component separation techniques and 35 botulinum toxin A. There was no difference in tobacco use, diabetes, or body mass index (all P > .5). Hernia defects and volume were large for both the component separation techniques and botulinum toxin A groups (mean size: component separation techniques 286.2 ± 179.9 cm2 vs botulinum toxin A 289.7 ± 162.4 cm2; P = .73) (mean volume: 1,498.3 + 2,043.4 cm3 vs 2,914.7 + 6,539.4 cm3; P = .35). Centers for Disease Control and Prevention wound classifications were equivalent (CDC3 and 4%-39.1% vs 40.0%; P = .97). Component separation techniques were more frequently performed in European Hernia Society M1 hernias (21% vs 2.9%; P = .01). The botulinum toxin A group had fewer surgical site occurrences (32.4% vs 11.4%; P = .02) and surgical site infections (11.7% vs 0%; P = .04). In multivariate analysis, botulinum toxin A was associated with lower rates of surgical site occurrences (odds ratio = 5.3; 95% confidence interval [1.4-34.4]). There was no difference in fascial closure (90.5% vs 100%; P = .11) or recurrence (12.4% vs 2.9%; P = .10) with follow-up (22.8 + 29.7 vs 9.8 + 12.7 months; P = .13). CONCLUSION: In a matched study comparing patients with botulinum toxin A versus component separation techniques, there was no difference in fascial closure rates or in hernia recurrence between the 2 groups. Preoperative botulinum toxin A can achieve similar outcomes as component separation techniques, while decreasing the frequency of surgical site occurrences.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Marturano MN, Ayuso SA, Ku D, et al. Preoperative botulinum toxin A (BTA) injection versus component separation techniques (CST) in complex abdominal wall reconstruction (AWR): A propensity-scored matched study. Surgery. 2022. PMID: 36229258. doi:10.1016/j.surg.2022.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。